Astonea Labs
BSE: ASTONEALAB · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Astonea Labs's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Astonea Labs Limited is an Indian pharmaceutical company specialising in the contract development and manufacturing of healthcare and personal care products. The company produces a diverse range of items including dermatology, cosmetics, herbal formulations, and general pharmaceuticals for domestic and international brands.
Business Model
The company operates as a contract development and manufacturing organisation (CDMO), generating revenue through outsourced manufacturing and private label production services. It leverages its manufacturing facilities to produce creams, lotions, soaps, and oral liquids for various third-party brands.
Management Commentary
Management focuses on scaling operations by enhancing research and development capabilities to meet the rising demand for outsourced pharmaceutical and wellness products.
Growth Outlook
Growth is driven by the expansion of formulation capabilities and an increased presence in the wellness and hygiene markets. The company aims to capitalise on the growing trend of outsourced pharmaceutical manufacturing and private label production.
Key Risks
- Regulatory Compliance. The company faces risks related to maintaining stringent quality standards and obtaining necessary approvals from health authorities for its manufacturing facilities.
- Client Concentration. As a contract manufacturer, the company may be vulnerable to the loss of key clients or fluctuations in demand from major partner brands.
- Input Cost Volatility. Fluctuations in the prices of raw materials and active pharmaceutical ingredients can impact the company's operating margins.
- Competitive Market. The pharmaceutical and personal care manufacturing sector is highly competitive, which may exert pressure on pricing and contract terms.
Start your research today
Unlock AI insights, financials, peers and live data on Astonea Labs and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Astonea LabsASTONEALAB | ₹290 Cr | — | — | — | 9.0% | — | — | +57.6% |
Albert DavidALBERTDAVD | ₹513 Cr | 22.73 | 13.48 | 11.4% | 11.0% | 5.8% | 7.5% | +12.1% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹463 Cr | 13.31 | 8.46 | — | 32.0% | 17.6% | 23.2% | -4.3% |
Haleos Labs LimitedHALEOSLABS | ₹452 Cr | 28.60 | 12.72 | -3.1% | 13.6% | 7.4% | 10.3% | — |
TranschemTRANSCHEM | ₹424 Cr | 98.76 | 68.07 | -100.0% | 177.7% | 5.3% | 7.0% | +592.6% |
Medicamen BiotecMEDICAMEQ | ₹338 Cr | 33.59 | 15.53 | 24.7% | 11.3% | 4.1% | 6.2% | -27.9% |
As of Mar 2026
Financials
Astonea Labs
BSE: ASTONEALAB · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Astonea Labs's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Astonea Labs Limited is an Indian pharmaceutical company specialising in the contract development and manufacturing of healthcare and personal care products. The company produces a diverse range of items including dermatology, cosmetics, herbal formulations, and general pharmaceuticals for domestic and international brands.
Business Model
The company operates as a contract development and manufacturing organisation (CDMO), generating revenue through outsourced manufacturing and private label production services. It leverages its manufacturing facilities to produce creams, lotions, soaps, and oral liquids for various third-party brands.
Management Commentary
Management focuses on scaling operations by enhancing research and development capabilities to meet the rising demand for outsourced pharmaceutical and wellness products.
Growth Outlook
Growth is driven by the expansion of formulation capabilities and an increased presence in the wellness and hygiene markets. The company aims to capitalise on the growing trend of outsourced pharmaceutical manufacturing and private label production.
Key Risks
- Regulatory Compliance. The company faces risks related to maintaining stringent quality standards and obtaining necessary approvals from health authorities for its manufacturing facilities.
- Client Concentration. As a contract manufacturer, the company may be vulnerable to the loss of key clients or fluctuations in demand from major partner brands.
- Input Cost Volatility. Fluctuations in the prices of raw materials and active pharmaceutical ingredients can impact the company's operating margins.
- Competitive Market. The pharmaceutical and personal care manufacturing sector is highly competitive, which may exert pressure on pricing and contract terms.
Start your research today
Unlock AI insights, financials, peers and live data on Astonea Labs and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026